Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Sally Beauty Holdings, Inc.Sally Beauty Reports Q3 Fiscal 2025 Results: Decline in Sales but Increase in Profitability
HALOZYME THERAPEUTICS, INC.Halozyme Therapeutics Reports 41% Revenue Growth to $325.7 Million in Q2 2025
Biomea Fusion, Inc.Biomea Fusion Reports $20.7 Million Net Loss in Q2 2025, Seeks Additional Financing
AVANOS MEDICAL, INC.Avanos Medical Reports $76.8 Million Net Loss in Q2 2025 Amid Restructuring Efforts
American Well CorpAmerican Well Corporation Reports 13% Revenue Growth and Improved Operational Efficiency in Q2 2025
REVVITY, INC.Revvity Reports 4% Revenue Growth to $720.3 Million in Q2 2025
SSR MINING INC.SSR Mining Inc. Reports 119.4% Revenue Increase to $405.5 Million in Q2 2025
MEDALLION FINANCIAL CORPMedallion Financial Reports Increased Net Income and Interest Income in Q2 2025
INTERFACE INCInterface, Inc. Reports 8.3% Revenue Growth in Q2 2025, Raises Full-Year Outlook
Upstart Holdings, Inc.Upstart Holdings Reports $5.6 Million Net Income and $257.3 Million Revenue for Q2 2025
Pacira BioSciences, Inc.Pacira BioSciences Reports Q2 2025 Revenue Growth but Net Loss
National Storage Affiliates TrustNational Storage Affiliates Trust Reports Q2 2025 Revenue Decline to $188.8 Million
ZEBRA TECHNOLOGIES CORPZebra Technologies Reports 6.2% Sales Growth to $1.293 Billion in Q2 2025
Vera Therapeutics, Inc.Vera Therapeutics Reports $76.5 Million Net Loss in Q2 2025 Amid Increased R&D Expenses
DOUGLAS DYNAMICS, INCDouglas Dynamics Reports Q2 2025 Financial Results with Increased Net Income
SLR Investment Corp.SLR Investment Corp. Reports Q2 2025 Financial Results with $21.6M Net Investment Income
Day One Biopharmaceuticals, Inc.Day One Biopharmaceuticals Reports 313.9% Revenue Increase in Q2 2025
Frontdoor, Inc.Frontdoor, Inc. Reports 14% Revenue Growth to $617 Million in Latest Quarter
TopBuild CorpTopBuild Reports Q2 2025 Financial Results with $151.6M Net Income and Revenue Decline
Allison Transmission Holdings IncAllison Transmission Reports Slight Decline in Net Sales but Increase in Profitability for Q2 2025
RIGEL PHARMACEUTICALS INCRigel Pharmaceuticals Reports $101.7 Million in Quarterly Revenues, Significant Net Income Turnaround
Spyre Therapeutics, Inc.Spyre Therapeutics Reports $36.7 Million Net Loss, Decreases Total Assets to $538.8 Million
Xometry, Inc.Xometry Reports 23% Revenue Growth to $162.5 Million in Q2 2025
Personalis, Inc.Personalis Reports 24% Revenue Decline and $20.1 Million Net Loss in Q2 2025
TransDigm Group INCTransDigm Reports 9.3% Revenue Growth to $2.24 Billion in Q3 Fiscal 2025